Published online December 29, 2008
PEDIATRICS Vol. 123 No. 1 January 2009, pp. 256-261 (doi:10.1542/10.1542/peds.2007-2840)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halliday, J.
Right arrow Articles by Muggli, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halliday, J.
Right arrow Articles by Muggli, E.
Related Collections
Right arrow Genetics & Dysmorphology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Has Prenatal Screening Influenced the Prevalence of Comorbidities Associated With Down Syndrome and Subsequent Survival Rates?

Jane Halliday, PhDa,b, Veronica Collins, PhDa, Merilyn Riley, BAppl Scib, Danielle Youssef, BAppl Scib and Evelyne Muggli, MPHa

a Murdoch Childrens Research Institute, Parkville, Victoria, Australia
b Victorian Birth Defects Register, Department of Human Services, Victoria, Australia

OBJECTIVES. With this study we aimed to compare survival rates for children with Down syndrome in 2 time periods, 1 before prenatal screening (1988–1990) and 1 contemporaneous with screening (1998–2000), and to examine the frequency of comorbidities and their influence on survival rates.

METHODS. Record-linkage was performed between the population-based Victorian Birth Defects Register and records of deaths in children up to 15 years of age collected under the auspice of the Consultative Council on Obstetric and Pediatric Mortality and Morbidity. Cases of Down syndrome were coded according to the presence or absence of comorbidities by using the International Classification of Diseases, Ninth Revision classification of birth defects. Kaplan-Meier survival functions and log rank tests for equality of survival distributions were performed.

RESULTS. Of infants liveborn with Down syndrome in 1998–2000, 90% survived to 5 years of age, compared with 86% in the earlier cohort. With fetal deaths excluded, the proportion of isolated Down syndrome cases in the earlier cohort was 48.7% compared with 46.1% in the most recent cohort. In 1988–1990 there was at least 1 cardiac defect in 41.1% of cases and in 45.4% in 1998–2000. There was significant variation in survival rates for the different comorbidity groupings in the 1988–1990 cohort, but this was not so evident in the1998–2000 cohort.

CONCLUSIONS. Survival of children with Down syndrome continues to improve, and there is an overall survival figure of 90% to at least 5 years of age. It is clear from this study that prenatal screening technologies are not differentially ascertaining fetuses with Down syndrome and additional defects, because there has been no proportional increase in births of isolated cases with Down syndrome.


Key Words: comorbidity • congenital abnormalities/anomalies • Down syndrome • prenatal • survival rate

Abbreviations: DS—Down syndrome • NT—nuchal translucency • VBDR—Victorian Birth Defects Registry • CCOPMM—Consultative Council of Obstetric and Pediatric Morbidity and Mortality • df—degrees of freedom


Accepted Apr 22, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?